Global Glucose Sensors Market, By Product (Invasive Glucose Monitoring, Non-Invasive Glucose Monitoring , Self-Glucose Monitoring ,Lab-Based Glucose Monitoring), Technology (Photo Acoustic Spectroscopy, Optical Coherence Tomography, Polarimetry, Fluorescence, MIR Spectroscopy, NIR Spectroscopy, Impedance Spectroscopy, Skin Suction Blister Technique, Sonophoresis, Reverse Iontophoresis), Component (Sensors, Transmitters & Receivers, Integrated Insulin Pumps), Demographics (Adult Population (>14 years), Children Population (≤14 years), End-Users (Hospitals, Private Clinics, Home Care, Ambulatory Settings, Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
The rise in the diabetic population drives the market, as does the increased use of blood glucose monitoring devices. Obesity is also regarded as a major contributor to the disease, particularly Type 2 diabetes. Other factors, such as technological advancements and innovations, provide many advantages in measuring blood glucose levels. Continuous glucose monitoring devices are one such advancement in monitoring blood glucose levels. These devices aid in the detection of hypoglycaemic and hyperglycaemic conditions.
Data Bridge Market Research analyses that the glucose sensors market is expected to reach the value of USD 8786.65 million by the year 2029, at a CAGR of 19.85% during the forecast period. The glucose sensors market is being driven by an increase in the number of diabetic patients. North America dominates the population glucose sensors market due to rising healthcare costs, rising healthcare expenditure, and an increase in the prevalence of chronic diseases in this region
Glucose sensors are compact analytical devices or elements that combine a biological or biologically derivative sensitive recognition section with a physiochemical transducer. These sensors are critical for oral glucose lowering medication or insulin treatment because they provide data on glucose concentrations in the body. These sensors are very effective at monitoring the level of glucose in the human body.
Report Scope and Market Segmentation
2022 to 2029
2020 (Customizable to 2014 - 2019)
Revenue in USD Million, Volumes in Units, Pricing in USD
Product (Invasive Glucose Monitoring, Non-Invasive Glucose Monitoring , Self-Glucose Monitoring ,Lab-Based Glucose Monitoring), Technology (Photo Acoustic Spectroscopy, Optical Coherence Tomography, Polarimetry, Fluorescence, MIR Spectroscopy, NIR Spectroscopy, Impedance Spectroscopy, Skin Suction Blister Technique, Sonophoresis, Reverse Iontophoresis), Component (Sensors, Transmitters & Receivers, Integrated Insulin Pumps), Demographics (Adult Population (>14 years), Children Population (≤14 years), End-Users (Hospitals, Private Clinics, Home Care, Ambulatory Settings, Others),
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Abbott (U.S.), Arkay, Inc. (U.S.), Bayer Healthcare AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Goldsite Diagnostics Inc., GlySure Ltd (U.K), Sphere Medical Holding plc. (U.K), Dexcom, Inc. (U.S.), and LifeScan, Inc. (U.S.)
Glucose Sensors Market Dynamics
- The rise in the research and development activities
Increased R&D investments are a critical factor driving market growth, as is an increase in the accuracy and precision of the sensor's data, an increase in healthcare expenditure, an increase in the geriatric population, an increase in the number of product launches, and an increase in the prevalence of diabetes, among other factors driving the glucose sensors market.
The increase in the healthcare spending and pipeline products
Rise in pipeline products and ongoing research and development activities in the market will create new opportunities for the glucose sensors market during the forecasted period.
- Government investments for healthcare interoperability
The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the glucose sensors market.
High cost and poor reimbursement of blood glucose monitoring systems and supplies, as well as strict rules and high cost of sensors, are among the major factors that will obstruct market growth and will further challenge the growth of the glucose sensors market during the forecast period.
This glucose sensors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glucose sensors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Glucose Sensors Market
The demand for all self-monitoring devices skyrocketed thanks to online sales channels. This was due primarily to the lockdown and stockpiling of blood glucose monitors. Because diabetic patients are more likely to develop complications from COVID-19 and other major illnesses, the demand for continuous glucose monitoring and related alarm systems is expected to rise in the coming years. When compared to the market size in 2019, the global market for blood glucose monitoring increased by 15% in 2020.
- Roche announced the launch of the new Accu-Chek Instant system in February 2021, a new "connected" blood glucose monitoring (BGM) system that supports and enables Roche's integrated Personalised Diabetes Management approach (iPDM). Accu-Chek Instant has Bluetooth connectivity to the mySugr app, allowing for wireless transfer of blood glucose results.
- In August 2021, HAGAR, the creator of GWave technology, which uses RF waves to measure glucose levels in the blood, will release it. Columbia Pacific, a returning investor, led a USD 11.7 million Series B funding round for HAGAR. This round's funding will be used for upcoming trials for FDA approval, as well as to complete international patents.
Global Glucose Sensors Market Scope
The glucose sensors market is segmented on the basis of product, technology, component, demographics and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Invasive Glucose Monitoring
- Non-Invasive Glucose Monitoring
- Self-Glucose Monitoring
- Lab-Based Glucose Monitoring
On the basis of product, glucose sensors market is segmented into invasive glucose monitoring, non-invasive glucose monitoring, self-glucose monitoring and lab-based glucose monitoring.
- Photo Acoustic Spectroscopy
- Optical Coherence Tomography
- MIR Spectroscopy
- NIR Spectroscopy
- Impedance Spectroscopy
- Skin Suction Blister Technique
- Reverse Iontophoresis
Based on technology, glucose sensors market is segmented into photo acoustic spectroscopy, optical coherence tomography, polarimetry, fluorescence, MIR spectroscopy, NIR spectroscopy, impedance spectroscopy, skin suction blister technique, sonophoresis and reverse iontophoresis.
- Transmitters & Receivers
- Integrated Insulin Pumps
Based on component, the glucose sensors market is segmented into sensors, transmitters & receivers and integrated insulin pumps.
- Adult Population (>14 years)
- Children Population (≤14 years)
Based on demographics, the glucose sensors market is segmented into adult population (>14 years) and children population (≤14 years).
- Private Clinics
- Home Care
- Ambulatory Settings
The glucose sensors market is also segmented on the basis of end-users into hospitals, private clinics, home are, ambulatory settings and others.
Glucose Sensors Market Regional Analysis/Insights
The glucose sensors market is analysed and market size insights and trends are provided by country, product, technology, component, demographics and end-users as referenced above.
The countries covered in the glucose sensors market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the glucose sensors market due to rising healthcare costs, rising healthcare expenditure, and an increase in the prevalence of chronic diseases in this region. Asia-Pacific is expected to be the fastest growing region in terms of glucose sensors market growth, owing to rising healthcare expenditure and increasing demand for effective disease management strategies in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The glucose sensors market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for glucose sensors market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the glucose sensors market. The data is available for historic period 2010-2020.
Competitive Landscape and Glucose Sensors Market Share Analysis
The glucose sensors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to glucose sensors market.
Some of the major players operating in the glucose sensors market are Abbott (U.S.)
- Arkay, Inc. (U.S.)
- Bayer Healthcare AG (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Goldsite Diagnostics Inc.(US)
- GlySure Ltd (U.K)
- Sphere Medical Holding plc. (U.K)
- Dexcom, Inc. (U.S.)
- LifeScan, Inc. (U.S)